SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables)

6 Months Ended

Dec. 31, 2012

Jun. 30, 2012

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION [Abstract]

Schedule of Accounts Receivable

				December 31,
	June 30, 2012			2011			2010
	($ in thousands)
1) Trade:
Open accounts	$	2,039		$	2,426		$	998
Allowance for doubtful accounts		(215	)		(142	)		(146	)
	$	1,824		$	2,284		$	852
2) Other:
Due from government institutions	$	124		$	68		$	56
Advance payments to suppliers		118			32
Fund in respect of employee right upon retirement								8
Miscellaneous		22			18			11
	$	264		$	118		$	75

Schedule of Changes in Allowance for Doubtful Accounts

	6 month period ended June 30, 2012			Year ended December 31
				2011			2010		2009
	($ in thousands)
Balance at beginning of period	$	142		$	146		$	6	$	6
Additions during the period		78						140
Exchange rate differences		(5	)		(4	)
Balance at end of period	$	215		$	142		$	146	$	6

Schedule of Inventories

	December 31, 2012		June 30, 2012
	($ in thousands)
Finished goods	$	378	$	479
Work in process		1,484		1,115
Raw materials and supplies		115		150
	$	1,977	$	1,744

			December 31,
	June 30, 2012		2011		2010
	($ in thousands)
Finished goods	$	479	$	741	$	957
Work in process		1,115		1,044		573
Raw materials and supplies		150		276		174
	$	1,744	$	2,061	$	1,704

Schedule of Inventory on Consignment

	6 month period ended June 30, 2012			Year ended December 31,
				2011			2010			2009
	($ in thousands)
Balance at beginning of period	$	110		$	371		$	1,093		$	1,423
Costs of revenues deferred during the period		20			110			326			421
Costs of revenues recognized during the period		(67	)		(371	)		(1,048	)		(751	)
Balance at end of period	$	63		$	110		$	371		$	1,093

Schedule of Accounts Payable and Accruals

	December 31, 2012		June 30, 2012
	($ in thousands)
Employees and employee institutions	$	394	$	438
Accrued vacation and recreation pay		278		272
Accrued clinical trial expenses		552		607
Provision for sales commissions		155		194
Accrued expenses		841		1,197
Due to government institutions				22
Provision for returns		53		139
Taxes payable		103		56
	$	2,376	$	2,925

			December 31,
	June 30, 2012		2011		2010
	($ in thousands)
Employees and employee institutions	$	438	$	376	$	382
Accrued vacation and recreation pay		272		271		147
Accrued clinical trials expenses		607		124		35
Provision for sales commissions		194		213		36
Accrued expenses		1,197		930		561
Due to government institutions		22		3		100
Liability for employees rights upon retirement						7
Provision for returns		139		231		150
Taxes payable		56		69		98
	$	2,925	$	2,217	$	1,509

Schedule of Deferred Revenues

	6 month period ended June 30, 2012			Year ended December 31
				2011			2010			2009
	($ in thousands)
Balance at beginning of period	$	-		$	398		$	1,975		$	2,482
Revenue deferred during the period		25						320			616
Revenue recognized during the period		(15	)		(398	)		(1,897	)		(1,123	)
Balance at end of period	$	10		$	-		$	398		$	1,975

Schedule of Financial Expenses (Income), Net

	Three months ended December 31,						Six months ended December 31,
	2012			2011			2012			2011
	($ in thousands)						($ in thousands)
Bank commissions	$	8		$	8			17		$	16
Interest income		(6	)		(11	)		(15	)		(32	)
Exchange rate differences		(81	)		32			(75	)		138
Interest expense (including debt issuance costs)		1,120			10			2,108			25
Change in fair value of warrants and embedded derivatives		(3,529	)					(305	)
	$	(2,488	)	$	39		$	1,730		$	147

	6 month period ended June 30, 2012			Year ended December 31
				2011			2010			2009
	($ in thousands)
Bank commissions	$	30		$	63		$	83		$	18
Interest income		(9	)		(36	)		(1	)		(1	)
Exchange rate differences		(40	)		177			(33	)		30
Interest expense (including debt issuance costs)		1,232			730			105			221
Change in fair value of warrants and embedded derivatives		(1,322	)
Redemption of beneficial conversion feature of convertible loan											(308	)
	$	(109	)	$	934		$	154		$	(40	)